Erythropoietin Stimulating Agents: Therapeutic Applications and Global Markets

  • ID: 3634300
  • Report
  • Region: Global
  • 164 Pages
  • BCC Research
1 of 6
The Global Market for Erythropoietin Stimulating Agents (ESAS) Will Grow from Nearly $7.2 Billion in 2015 to Nearly $7.3 Billion by 2020

FEATURED COMPANIES

  • 3Sbio Inc.
  • Blausiegel
  • Dr. Reddy's Laboratories.
  • La Renon Healthcare
  • Probiomed
  • Shantha Biotechnics
  • MORE
This report provides an up-to-date analysis of recent developments and current trends in the global erythropoietin drug market. Includes forecast through 2020.

This report provides:
- An overview of the global markets and therapeutic applications for erythropoietin stimulating agents (ESAs).
- Analyses of U.S. as well as international market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Coverage of the market in value terms broken down by major types of erythropoietin, by major regions, and by applications.
- Coverage of applications including cancer therapy, chronic kidney disease (CKD) therapy, HIV therapy, and anemia therapy.
- Major trends and challenges affecting the market and the supplier landscape.
- A look at industrial developments and the advent of biosimilars impacting the market.
- Analysis of the risks associated with the market for abusive uses of ESAa and their adverse effects.
- Profiles of major players in the industry.

Use this report to:

- Gain information about the various types applications of erythropoietin stimulating agents.
- Analyze current trends within the industry, major industry challenges, and the regional dynamics of the global erythropoietin drug market.
- Quantify the projected impact of both internal and external forces affecting the global erythropoietin drug market today and over the next several years.
- Analyze detailed profiles of major vendors in the erythropoietin drug industry globally.

Study Goals And Objectives:
The goal of this report is to provide an up-to-date analysis of recent developments and current trends in the global erythropoietin drug market. The objective of this type of systematic research is to quantify the projected impact of both internal and external forces that are affecting the global erythropoietin drug market today and that will affect the industry for the next several years. Factors involved in driving product demand within this vast untapped market will be explored in conjunction with trends, potential sales and forecasts for various market sectors. In addition, major players
closely involved in the production of these erythropoietin drugs, as well as their upcoming and anticipated products resulting from further research and development will be analyzed to demonstrate how these advances might influence the existing erythropoietin drugs market.

Reasons For Doing The Study:
Increasing cases of chronic kidney diseases, oncology diseases; and anemia in HIV patients across regions and the expiry of Epogen’s patent in 2015, and upcoming patent expiry of Aranesp in Europe is expected to increase the demand for the global erythropoietin biosimilar drug market.

Scope Of Report:
The scope of this report is broad and covers erythropoietin drug used globally in various types of applications. The market is broken down in terms of the various types of erythropoietin drug by region and by applications. Revenue forecasts from 2015 to 2020 are given for erythropoietin drug, with its applications and regional markets. The report also includes a discussion of the major players in each of the regional markets for erythropoietin drug. It explains the major market drivers of the global erythropoietin drug industry, the current trends within the industry, major industry challenges and the regional dynamics of the global erythropoietin drug market. The report concludes with a special focus on the supplier landscape. It includes detailed profiles of the major vendors in the erythropoietin drug industry globally.

Intended Audience:
This report is intended especially for developers, as well as consumers with a vital interest in erythropoietin drug and its application. In addition, because of this report’s business focus, it will be useful to sales executives and business managers as an up-to-date guide that includes challenges, drivers and trends that are expected to be significant factors in the current and future markets. The report should also be of interest to those in industries such as erythropoietin drug raw materials (manufacturers and suppliers), healthcare consulting companies, laboratory equipment manufacturers and pharmaceutical manufacturers.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 3Sbio Inc.
  • Blausiegel
  • Dr. Reddy's Laboratories.
  • La Renon Healthcare
  • Probiomed
  • Shantha Biotechnics
  • MORE
Chapter 1: Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Scope Of Report
- Intended Audience
- Information Sources
- Research Methodology
- Analysts' Credentials
- Disclaimer

Chapter 2: Summary

Chapter 3: Overview
- Definition
- Erythropoietin As A Drug
- Developmental Stages Of Erythropoietin
- Applications Of Erythropoietin
- Side Effects Of Erythropoietin
- Pros And Cons Of Manufacturing Methods:

Chapter 4: R&D Drug Pipeline

Chapter 5: Global Market Forecast For Erythropoietin Drug
- Global Market Forecast For Erythropoietin Drugs By Category
- Global Market Forecast For Erythropoietin Drugs By Type
- Global Market Forecast For Erythropoietin Biologic Drugs By Type
- Global Market Forecast For Erythropoietin Biosimilar Drugs By Type
- Global Market Forecast For Erythropoietin Drugs By Application
- Global Market Forecast For Erythropoietin Drugs By Region
- Global Market Forecast For Erythropoietin Drugs By Region
- Global Market Forecast For Erythropoietin Drugs By Application
- Global Market Forecast For Epoetin-Alfa Drugs By Region
- Global Market Forecast For Epoetin-Beta Drugs By Region
- Global Market Forecast For Erythropoietin Darbepoetin-Alfa Drugs By Region
- Global Market Forecast For Other Erythropoietinbiologic Drugs By Region
- Global Market Forecast For Erythropoietin Drugs For Kidney Diseases By Region
- Global Market Forecast For Erythropoietin Drugs For Oncology Diseases By Region
- Global Market Forecast For Erythropoietin Drugs For Other Diseases By Region
- Global Market Forecast For Epoetin-Alfa Drugs By Application
- Global Market Forecast For Epoetin-Beta Drugs By Application
- Global Market Forecast For Darbepoetin-Alfa By Application
- Global Market Forecast For Other Erythropoietin Biologic Drugs By Application
- Global Market Forecast For Epogen Drugs By Region
- Global Market Forecast For Epogen Drugs By Application
- Global Market Forecast For Procrit Drugs By Region
- Global Market Forecast For Procrit Drugs By Application
- Global Market Forecast For Eprex Drugs By Region
- Global Market Forecast For Eprex Drugs By Application
- Global Market Forecast For Aranesp Drugs By Region
- Global Market Forecast For Aranesp Drugs By Application
- Global Market Forecast For Neorecormon Drugs By Region
- Global Market Forecast For Neorecormon Drugs By Application
- Global Market Forecast For Mircera Drugs By Region
- Global Market Forecast For Mircera By Application

Chapter 6: Drivers And Challenges
- Increasing Cases Of Chronic Kidney Disease
- Increasing Prevalence Of Cancer
- Risk Of Thrombosis And Pure Red Cell Aplasia (Prca)
- Increasing Generic Competition

Chapter 7: Vendor Landscape And Company Profiles
- 3Sbio Inc.
- Amega Biotech
- Amgen Inc.
- Biocon
- Biosidus
- Blausiegel
- Celon Labs
- Center Of Molecular Immunology
- Chalver Laboratories
- Cj Healthcare
- Claris Lifesciences
- Dr. Reddy's Laboratories.
- Emcure Pharmaceuticals
- Hindustan Antibiotics
- Hospira Inc.
- Intas Biopharmaceutical Ltd
- Jcr Pharmaceuticals Co. Ltd.
- Johnson & Johnson
- Landsteiner Scientific S.A. De C.V.
- La Renon Healthcare
- Lg Life Sciences
- Lupin Ltd.
- Medice Drug Putter Gmbh & Co. Kg
- Novartis International Ag
- Panacea Biotec
- Probiomed
- Reliance Life Sciences
- Roche
- Rpg Life Sciences
- Serum Institute Of India
- Shanghai Chemo Wanbang Biopharma Co. Ltd.
- Shantha Biotechnics
- Stada Arzneimittel Ag
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vhb Life Sciences Ltd.
- Wockhardt Limited
- Zuventus Health Care
- Zydus Cadila Healthcare

List Of Tables

- Summary Table : Global Market For Erythropoietin Drugs By Type, Through 2020
- Table 1 : Major Epo R&D Drug Pipeline By Trial Phase
- Table 2 : Global Market For Erythropoietin Drugs By Category, Through 2020
- Table 3 : Global Market For Erythropoietin Drugs By Type, Through 2020
- Table 4 : Global Market For Erythropoietin Biologic Drugs By Type, Through 2020
- Table 5 : Global Market For Erythropoietin Biosimilar Drugs By Type, Through 2020
- Table 6 : Global Market For Erythropoietin Drugs By Application, Through 2020
- Table 7 : Global Market Forecast For Erythropoietin Drugs By Region, Through 2020
- Table 8 : Global Market For Erythropoietin Biologic Drugs By Region, Through 2020
- Table 9 : Global Market For Erythropoietin Biosimilar Drugs By Region, Through 2020
- Table 10 : Global Market Forecast For Erythropoietin Biologic Drugs By Application, Through 2020
- Table 11 : Global Market For Erythropoietin Biosimilar Drugs By Application, Through 2020
- Table 12 : Global Market For Epoetin-Alfa Drugs By Region, Through 2020
- Table 13 : Global Market For Epoetin-Beta Drugs By Region, Through 2020
- Table 14 : Global Market For Erythropoietin Darbepoetin-Alfa Drugs By Region, Through 2020
- Table 15 : Global Market For Other Erythropoietin Biologic Drugs By Region, Through 2020
- Table 16 : Global Market For Erythropoietin Drugs For Kidney Diseases By Region, Through 2020
- Table 17 : Global Market For Erythropoietin Drugs Oncology Diseases By Region, Through 2020
- Table 18 : Global Market Forecast For Erythropoietin Drugs For Other Diseases By Region, Through 2020
- Table 19 : Global Market For Epoetin-Alfa Drugs By Application, Through 2020
- Table 20 : Global Market For Epoetin-Beta Drugs By Application, Through 2020
- Table 21 : Global Market For Darbepoetin-Alfa Drugs By Application, Through 2020
- Table 22 : Global Market For Other Erythropoietin Biologic Drugs By Application, Through 2020
- Table 23 : Global Market For Epogen Drugs By Region, Through 2020
- Table 24 : Global Market For Epogen Drugs By Application, Through 2020
- Table 25 : Global Market For Procrit Drugs By Region, Through 2020
- Table 26 : Global Market For Procrit Drugs By Application, Through 2020
- Table 27 : Global Market For Eprex Drugs By Region, Through 2020
- Table 28 : Global Market For Eprex Drugs By Application, Through 2020
- Table 29 : Global Market For Aranesp Drugs By Region, Through 2020
- Table 30 : Global Market For Aranesp Drugs By Application, Through 2020
- Table 31 : Global Market For Neorecormon Drugs By Region, Through 2020
- Table 32 : Global Market For Neorecormon Drugs By Application, Through 2020
- Table 33 : Global Market For Mircera Drugs By Region, Through 2020
- Table 34 : Global Market For Mircera Drugs By Application, Through 2020
- Table 35 : Global Prevalence Of Hypertension By Region, 2000-2025
- Table 36 : U.S. Incident Of Esrd Based On Diseases, 2011 And 2012
- Table 37 : Global Population Over The Age Of 60, Through 2020
- Table 38 : U.S. Incident Of Esrd Based On Ethnicity, 2011 And 2012
- Table 39 : Incidence Of Anemia By Chemotherapy Agents
- Table 40 : Global Erythropoietin Biologic Drugs Market Share By Manufacturer, 2014
- Table 41 : 3Sbio's Recent Financial Performance, Through 2014
- Table 42 : Amgen's Erythropoetin Drugs Pipeline
- Table 43 : Amgen's Erythropoetin Drugs Patents
- Table 44 : Aranesp's Sales By Region, Through 2014
- Table 45 : Epogen's Sales By Region, 2011-2014
- Table 46 : Amgen's Recent Financial Performance, Through 2014
- Table 47 : Biocon's Recent Financial Performance, Through 2014
- Table 48 : Claris Lifesciences' Recent Financial Performance, Through 2014
- Table 49 : Dr. Reddy's Recent Financial Performance, Through 2014
- Table 50 : Hospira's Recent Financial Performance, Through 2014
- Table 51 : Intas' Recent Financial Performance, Through 2014
- Table 52 : Jcr Pharmaceuticals' Recent Financial Performance, Through 2015
- Table 53 : Johnson & Johnson's Erythropoetin Sales, Through 2014
- Table 54 : Johnson & Johnson's Recent Financial Performance, Through 2014
- Table 55 : Lg Lifesciences' Recent Financial Performance, Through 2014
- Table 56 : Lupin's Recent Financial Performance, Through 2014
- Table 57 : Novartis' Recent Financial Performance, Through 2014
- Table 58 : Compositions Of Erythropoietin Manufactured By Panacea
- Table 59 : Panacea Biotec's Recent Financial Performance, Through 2014
- Table 60 : Roch's Erythropoetin Sales By Product, Through 2014
- Table 61 : Neorecormon/Epogin Sales By Region, Through 2014
- Table 62 : Mircera Sales By Region, Through 2014
- Table 63 : Roche's Recent Financial Performance, Through 2014
- Table 64 : Rpg Lifesciences Recent Financial Performance, Through 2014
- Table 65 : Stada Arzneimittel's Recent Financial Performance, Through 2014
- Table 66 : Sun Pharmaceutical's Recent Financial Performance, Through 2014
- Table 67 : Teva's Recent Financial Performance, Through 2014
- Table 68 : Wockhardt's Recent Financial Performance, Through 2014
- Table 69 : Zydus Cadila's Recent Financial Performance, Through 2014

List Of Figures

- Summary Figure : Global Market For Erythropoietin Drugs By Type, 2014-2020
- Figure 1 : Global Market Share For Erythropoietin Drugs By Category, 2015 And 2020
- Figure 2 : Global Market Share For Erythropoietin Drugs By Type, 2015 And 2020
- Figure 3 : Global Market Share For Erythropoietin Biologic Drugs By Type, 2015 And 2020
- Figure 4 : Global Market Share For Erythropoietin Biosimilar Drugs By Type, 2015 And 2020
- Figure 5 : Global Market Share For Erythropoietin Drugs By Application, 2015 And 2020
- Figure 6 : Global Market Share For Erythropoietin Drugs By Region, 2015 And 2020
- Figure 7 : Global Market Share For Erythropoietin Biologic Drugs By Region, 2015 And 2020
- Figure 8 : Global Market Share For Erythropoietin Biosimilar Drugs By Region, 2015 And 2020
- Figure 9 : Global Market Share For Erythropoietin Biologic Drugs By Application, 2015 And 2020
- Figure 10 : Global Market Share For Erythropoietin Biosimilar Drugs By Application, 2015 And 2020
- Figure 11 : Global Market Share For Epoetin-Alfa Drugs By Region, 2015 And 2020
- Figure 12 : Global Market Share For Epoetin-Beta Drugs By Region, 2015 And 2020
- Figure 13 : Global Market Share For Erythropoietin Darbepoetin-Alfa Drugs By Region, 2015 And 2020
- Figure 14 : Global Market Share For Other Erythropoietin Biologic Drugs By Region, 2015 And 2020
- Figure 15 : Global Market Share For Erythropoietin Drugs For Kidney Diseases By Region, 2015 And 2020
- Figure 16 : Global Market Share For Erythropoietin Drugs For Oncology Diseases By Region, 2015 And 2020
- Figure 17 : Global Market Share For Erythropoietin Drugs For Other Diseases By Region, 2015 And 2020
- Figure 18 : Global Market Share For Epoetin-Alfa Drugs By Application, 2015 And 2020
- Figure 19 : Global Market Share For Epoetin-Beta Drugs By Application, 2015 And 2020
- Figure 20 : Global Market Share For Darbeppoietin-Alfa Drugs By Application, 2015 And 2020
- Figure 21 : Global Market Share For Other Erythropoietin Biologic Drugs By Application, 2015 And 2020
- Figure 22 : Global Market Share For Epogen Drugs By Region, 2015 And 2020
- Figure 23 : Global Market Share For Epogen Drugs By Application, 2015 And 2020
- Figure 24 : Global Market Share For Procrit Drugs By Region, 2015 And 2020
- Figure 25 : Global Market Share For Procrit Drugs By Application, 2015 And 2020
- Figure 26 : Global Market Share For Eprex Drugs By Region, 2015 And 2020
- Figure 27 : Global Market Share For Eprex Drugs By Application, 2015 And 2020
- Figure 28 : Global Market Share For Aranesp Drugs By Region, 2015 And 2020
- Figure 29 : Global Market Share For Aranesp Drugs By Application, 2015 And 2020
- Figure 30 : Global Market Share For Neorecormon Drugs By Region, 2015 And 2020
- Figure 31 : Global Market Share For Neorecormon Drugs By Application, 2015 And 2020
- Figure 32 : Global Market Share For Mircera Drugs By Region, 2015 And 2020
- Figure 33 : Global Market Share For Mircera Drugs By Application, 2015 And 2020
- Figure 34 : Number Of People Ages 20 To 79 With Diabetes, By Region, 2013 And 2035
- Figure 35 : Number Of People Ages 20 To 79, Affected By Diabetes By Top Ten Countries, 2013
- Figure 36 : Number Of People Ages 20 To 79, Affected By Diabetes, By Top Ten Countries, 2035
- Figure 37 : Number Of Americans Diagnosed With Diabetes, 2009-2013
- Figure 38 : Prevalence Of Hypertension In People Aged Above 25 Years By Region, 2008 And 2014
- Figure 39 : Global Cancer Prevalence By Type, 2012
- Figure 40 : Global Cancer Prevalence Based On Five Year Period By Type, 2008-2012
- Figure 41 : Cancer Prevalence In More Developed Regions By Type, 2012
- Figure 42 : Cancer Prevalence Based On Five Year Period In More Developed Regions By Type, 2008-2012
- Figure 43 : Cancer Prevalence In Less Developed Regions By Type, 2012
- Figure 44 : Cancer Prevalence Based On Five-Year Period In Less Developed Regions By Type, 2008-2012
- Figure 45 : Amgen's Revenue By Region, 2014
- Figure 46 : Amgen's Sales By Product, 2014
- Figure 47 : Biocon's Sales By Region, 2014
- Figure 48 : Biocon's Sales By Business Segment, 2014
- Figure 49 : Dr.Reddy's Sales By Segment, 2013-2014
- Figure 50 : Hospira's Sales By Region, 2014
- Figure 51 : Hospira's Sales By Business Segment, 2014
- Figure 52 : Intas' Sales By Region, 2014
- Figure 53 : Jcr Pharmaceuticals' Therapeutic Contribution, 2013-2014
- Figure 54 : Johnson & Johnson's Sales By Segment, 2014
- Figure 55 : Lupin's Sales By Region, 2014
- Figure 56 : Novartis' Sales Share By Business Segments, 2014
- Figure 57 : Novartis' International Ag Sales By Region, 2014
- Figure 58 : Panacea Biotec's Sales By Region, 2014
- Figure 59 : Rpg Lifesciences' Sales By Business Segment, 2014
- Figure 60 : Rpg Lifesciences' Sales By Region, 2014
- Figure 61 : Stada Arzneimittel's Therapeutic Contribution, 2014
- Figure 62 : Stada Arzneimittel's Sales By Region, 2014
- Figure 63 : Sun Pharmaceutical's Sales By Region, 2014
- Figure 64 : Sun Pharmaceutical's Therapeutic Contribution By Segment, 2014
- Figure 65 : Teva's Therapeutic Contribution By Segment, 2014
- Figure 66 : Teva's Sales By Region, 2014
- Figure 67 : Wockhardt's Sales By Region, 2014
- Figure 68 : Zydus Cadila's Sales By Region, 2014
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 3Sbio Inc.
  • Blausiegel
  • Dr. Reddy's Laboratories.
  • La Renon Healthcare
  • Probiomed
  • Shantha Biotechnics
  • MORE
The global market for erythropoietin drug can be broadly classified into two segments: biologics and biosimilars.

The major types of biologic erythropoietin drugs based on different biological properties are epoetin-alfa, epoetin-beta, darbepoetin-alfa and epoetin-theta. The major types of biosimilar erythropoietin drug based on the different biological properties are epoetin-zeta, epoetin-omega, epoetin-lambda and epoetin-delta.

The global erythropoietin biologics drug market has been growing in terms of value from the past 15 years in pace with the increasing prevalence of chronic kidney diseases throughout the world, however the market is expected to see decline in the forecast period due to expiry of major patented drugs in the U.S. and European markets; and due to the entrant of many biosimilar erythropoietin drug in the European
market since 2008 which are approximately 20% to 30% cheaper compared to patented drug.

The global erythropoietin biosimilars drug market has been growing rapidly in the last decade years, primarily due to the patent expiry of major erythropoietin biologic drug in European market and demand for cheaper priced erythropoietin drugs in the

Asia-Pacific, South America, Middle-east and African market. The study covered in this report has been conducted to analyze and quantify the emerging market opportunities for erythropoietin drug, as well as to highlight the key current research efforts that are driving erythropoietin drug into new applications.

In addition, major players of the erythropoietin drug, along with their upcoming and anticipated erythropoietin-related products are analyzed to demonstrate how these advances might impact global erythropoietin drug market. The application of erythropoietin drug is divided broadly into three types: chronic kidney diseases; oncology diseases; and other applications such as treatment of anemia in HIV patients.

The key drivers for the erythropoietin drug market are increasing case of chronic disease and increasing prevalence of cancer. Amgen Inc., Hoffmann-La Roche and Johnson & Johnson are some of the key players of biologics erythropoietin drug market. Sandoz (subsidiary of Novartis International AG), Hospira (subsidiary of Pfizer Inc.), 3SBio, BioSidus and Teva Pharmaceutical Industries Ltd. are some of the major players of biosimilar erythropoietin drugs market.

The market for erythropoietin in Asia-Pacific and South America is expected to grow at the fastest rate compared to other global markets, which are expected to decline. The entrant of erythropoietin biosimilars drugs in Europe and the U.S. will create a huge impact during the forecast period, resulting in a decline in the global erythropoietin drug market.

This report also highlights the supplier landscape with a focus on major companies, with detailed profiles given.
Note: Product cover images may vary from those shown
5 of 6
- 3Sbio Inc.
- Amega Biotech
- Amgen Inc.
- Biocon
- Biosidus
- Blausiegel
- Celon Labs
- Center Of Molecular Immunology
- Chalver Laboratories
- Cj Healthcare
- Claris Lifesciences
- Dr. Reddy's Laboratories.
- Emcure Pharmaceuticals
- Hindustan Antibiotics
- Hospira Inc.
- Intas Biopharmaceutical Ltd
- Jcr Pharmaceuticals Co. Ltd.
- Johnson & Johnson
- Landsteiner Scientific S.A. De C.V.
- La Renon Healthcare
- Lg Life Sciences
- Lupin Ltd.
- Medice Drug Putter Gmbh & Co. Kg
- Novartis International Ag
- Panacea Biotec
- Probiomed
- Reliance Life Sciences
- Roche
- Rpg Life Sciences
- Serum Institute Of India
- Shanghai Chemo Wanbang Biopharma Co. Ltd.
- Shantha Biotechnics
- Stada Arzneimittel Ag
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vhb Life Sciences Ltd.
- Wockhardt Limited
- Zuventus Health Care
- Zydus Cadila Healthcare
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll